OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic targeting of cellular senescence in diabetic macular edema: preclinical and phase 1 trial results
Sergio Crespo‐Garcia, Frédérik Fournier, Roberto Diaz-Marin, et al.
Nature Medicine (2024) Vol. 30, Iss. 2, pp. 443-454
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

A systems view of the vascular endothelium in health and disease
Hellmut G. Augustin, Gou Young Koh
Cell (2024) Vol. 187, Iss. 18, pp. 4833-4858
Open Access | Times Cited: 30

Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial
Joshua N. Farr, Elizabeth J. Atkinson, Sara J. Achenbach, et al.
Nature Medicine (2024) Vol. 30, Iss. 9, pp. 2605-2612
Closed Access | Times Cited: 18

Therapeutic targeting of senescent cells in the CNS
Markus Rießland, Methodios Ximerakis, Andrew A. Jarjour, et al.
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 12

Enhancing immunity during ageing by targeting interactions within the tissue environment
Olivia V. Bracken, Roel P. H. De Maeyer, Arne N. Akbar
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 1

Safety and Efficacy of Senolytic UBX1325 in Diabetic Macular Edema
Sharon Klier, J. Dananberg, Lauren Masaki, et al.
NEJM Evidence (2025) Vol. 4, Iss. 5
Closed Access | Times Cited: 1

Resilience to diabetic retinopathy
Anara Serikbaeva, Yanliang Li, Simón Ma, et al.
Progress in Retinal and Eye Research (2024) Vol. 101, pp. 101271-101271
Open Access | Times Cited: 8

Diabetic macular edema (DME): dissecting pathogenesis, prognostication, diagnostic modalities along with current and futuristic therapeutic insights
Ahmed Sermed Al Sakini, Abdulrahman Khaldoon Hamid, Zainab A. Alkhuzaie, et al.
International Journal of Retina and Vitreous (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5

Senescent endothelial cells: a potential target for diabetic retinopathy
Ying-Lu Liao, Yifan Fang, Jiaxing Sun, et al.
Angiogenesis (2024)
Open Access | Times Cited: 4

A new clinical age of aging research
Zhen Zhang, Renlei Yang, Zhike Zi, et al.
Trends in Endocrinology and Metabolism (2024)
Open Access | Times Cited: 4

Modulation of diabetes-related retinal pathophysiology by PTX3
Varun Pathak, Pietro Maria Bertelli, Edoardo Pedrini, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 41
Open Access | Times Cited: 4

Foselutoclax (UBX1325) for Diabetic Macular Edema — A Potential Novel Therapy?
Emily Y. Chew
NEJM Evidence (2025) Vol. 4, Iss. 5
Closed Access

Long COVID as a Disease of Accelerated Biological Aging: An Opportunity to Translate Geroscience Interventions
Areez Shafqat, Mary Clare Masters, Utkarsh Tripathi, et al.
Ageing Research Reviews (2024) Vol. 99, pp. 102400-102400
Closed Access | Times Cited: 3

The Landscape of Vascular Endothelial Growth Factor Inhibition in Retinal Diseases
Joseph B. Lin, Rajendra S. Apte
Investigative Ophthalmology & Visual Science (2025) Vol. 66, Iss. 1, pp. 47-47
Open Access

Senescence as a Therapeutic Target
Onkar Singh, Yasmin Ahmad, Swaraj Mohanty
(2025), pp. 297-307
Closed Access

Progerin mRNA Is Associated with Smoking and Signs of Increased Microvascular Damage in Patients with Diabetic Macular Edema
Marc‐Michael Zaruba, Reinhard Angermann, Simon Staggl, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2099-2099
Open Access

Recent advances and prospects of nanoparticle-based drug delivery for diabetic ocular complications
Siqi Wang, Hongyu Yang, Jiaying Zheng, et al.
Theranostics (2025) Vol. 15, Iss. 8, pp. 3551-3570
Open Access

The role of retinal pigment epithelial senescence and the potential of senotherapeutics in age-related macular degeneration
Yingying Chen, Feipeng Jiang, Yue Zeng, et al.
Survey of Ophthalmology (2025)
Closed Access

Mechanisms of cellular senescence-induced vascular aging: evidence of senotherapeutic strategies
Sophia Mahoney, Samuel I. Bloom, Douglas R. Seals, et al.
The Journal of Cardiovascular Aging (2025) Vol. 5, Iss. 1
Open Access

Peptides based on the interface of hnRNPA2B1-transthyretin complex repress retinal angiogenesis in diabetic retinopathy
Yixiu Chen, Lu Ye, Steve W. Cui, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access

Urinary clusterin is a biomarker of renal epithelial senescence and predicts human kidney disease progression
David Baird, Maximillian Reck, Ross Campbell, et al.
Kidney International Reports (2025)
Open Access

What do You Need to Know after Diabetes and before Diabetic Retinopathy?
Shiyu Zhang, Jia‐Ren Liu, Heng Zhao, et al.
Aging and Disease (2025)
Open Access

Editorial: Physiological and pathological changes of the retina associated with ageing
Ana I. Arroba, Eleni Beli, José R. Hombrebueno, et al.
Frontiers in Cellular Neuroscience (2025) Vol. 19
Open Access

Advancing Toward a World Without Vision Loss From Diabetes: Insights From The Mary Tyler Moore Vision Initiative Symposium 2024 on Curing Vision Loss From Diabetes
Ward Fickweiler, Konstantina Sampani, Dorene S. Markel, et al.
Translational Vision Science & Technology (2025) Vol. 14, Iss. 5, pp. 12-12
Open Access

Page 1 - Next Page

Scroll to top